Biotech Startup Secures $2.5 Million

BIND Biosciences Inc., a Waltham, Mass.-based biotech startup, has raised $2.5 million in Series A funding, according to a regulatory filing. Backers include Flagship Ventures and Polaris Venture Partners, while the company is run by former TransForm Pharmaceuticals president Paul Goldenheim.